Lonza Group AG | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
Lonza Group AG

BRIEF

published on 11/12/2024 at 07:05, 9 days 7 hours ago

Lonza Expands Bioconjugation Capabilities in Switzerland

Sustainability Lonza ADCs Bioconjugation Visp Expansion
PRESS RELEASE

published on 11/12/2024 at 07:00, 9 days 7 hours ago

Lonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites
Lonza announces expansion of bioconjugation capabilities in Visp (CH) with two new manufacturing suites, addressing market demand and offering expertise to a broad customer base

Expansion Manufacturing Lonza Bioconjugation Visp
BRIEF

published on 10/24/2024 at 07:05, 28 days 7 hours ago

Lonza Group AG Confirms 2024 Outlook Amid Strategic Expansions

Manufacturing Expansion Lonza 2024 Outlook Genentech Acquisition CDMO Business Performance Vertex Agreement
PRESS RELEASE

published on 10/24/2024 at 07:00, 28 days 7 hours ago

Q3 2024 Qualitative Update: Lonza Confirms Full-Year Outlook 2024
Lonza confirms Full-Year Outlook 2024 with flat year-on-year sales in CER and high 20s CORE EBITDA margin in Q3 performance update

Sales EBITDA Lonza Full-year Outlook Q3 Performance
BRIEF

published on 10/22/2024 at 07:05, 30 days 7 hours ago

Lonza Extends Partnership for Antibody-Drug Conjugates Supply

Lonza Manufacturing Expansion ADCs Bioconjugation Pharmaceutical Partnership
PRESS RELEASE

published on 10/22/2024 at 07:00, 30 days 7 hours ago

Lonza Extends Collaboration with Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates
Lonza extends collaboration with major pharmaceutical partner for integrated commercial supply of antibody-drug conjugates, including construction of dedicated bioconjugation capacity in Visp, and commercial antibody manufacturing for new ADC therapy

Lonza ADCs Commercial Supply Bioconjugation Pharmaceutical Partner
BRIEF

published on 10/03/2024 at 09:05, 1 month 18 days ago

Lonza Nominates David Meline as Independent Board Member

Board Of Directors Annual General Meeting Financial Experience Lonza Group David Meline
PRESS RELEASE

published on 10/03/2024 at 09:00, 1 month 18 days ago

Lonza Nominates David Meline as Independent Board Member
Lonza nominates David Meline, experienced CFO, for Board position. Olivier Verscheure not to seek re-election. Details on David's background and Lonza's activities

CFO Lonza Board Member David Meline Olivier Verscheure
BRIEF

published on 10/01/2024 at 16:50, 1 month 19 days ago

Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville

Acquisition Pharmaceuticals Lonza Biologics Vacaville
PRESS RELEASE

published on 10/01/2024 at 16:45, 1 month 19 days ago

Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche
Lonza completes acquisition of large-scale biologics site in Vacaville (US) from Roche, expanding US footprint and manufacturing capacity

Acquisition Manufacturing Lonza Roche Biologics

1 2 ... 5

Accesswire

Published on 11/21/2024 at 14:00, 10 minutes ago

Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 13:30, 40 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 40 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 10 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 10 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 14:00, 10 minutes ago

Form 8.3 - LOYS AG: Learning Technologies Group plc
Published on 11/21/2024 at 13:15, 55 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 35 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 55 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 2 hours 3 minutes ago

IVU AG publishes Quarterly Report Q3-2024

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 12 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 50 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 25 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 25 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE